Botulinum toxin in motor disorders

Anna Rita Bentivoglio, Alberto Albanese

Research output: Contribution to journalArticlepeer-review


Advances in the clinical use of botulinum neurotoxins continue. Of interest to the neurologist is the advanced practice in the treatment of focal dystonia and the new developments on other dyskinesias and on autonomic control of smooth muscle motility. New toxin serotypes are now being tested; their availability will improve clinical practice and will possibly lead to combined treatments. Indications in spasticity and in juvenile cerebral palsy are now under scrutiny. The combination of focal chemodenervation with specific rehabilitation procedures enables new development in this field.

Original languageEnglish
Pages (from-to)447-456
Number of pages10
JournalCurrent Opinion in Neurology
Issue number4
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Botulinum toxin in motor disorders'. Together they form a unique fingerprint.

Cite this